Interleukin-33 Involvement in Nonsmall Cell Lung Carcinomas: An Update
نویسندگان
چکیده
منابع مشابه
EUROPEAN RESPIRATORY UPDATE Update on nonsmall cell lung cancer
D espite recent advances and declining its incidence in males in Western countries, lung cancer remains the main cause of cancer deaths worldwide, mainly because of tobacco smoking epidemics in developing countries and the still moderate efficacy of therapeutic strategies [1–3]. More than 80% of lung cancers are nonsmall cell lung cancer (NSCLC), which can be further sub-divided into squamous c...
متن کاملUpdate in PET imaging of nonsmall cell lung cancer.
u m b n i t w a o v o c n a e i ONSMALL CELL Lung cancer (NSCLC) is the leading cause of cancer death in both en and women in the United States. Despite ontinuing developments in diagnosis and treatent, the mortality from lung cancer remains high, ith an overall 5-year survival rate of only 15%.1 he primary treatment of lung cancer is surgery, nd the best chance for a complete cure comes rom to...
متن کاملClinicopathological features of nonsmall cell lung carcinomas with BRAF mutations.
BACKGROUND Recently, driver tyrosine kinase gene mutations have been detected in malignant tumors, including lung tumors. Notwithstanding their attractiveness as targets for molecular therapy, limited information is available regarding BRAF-mutated lung carcinomas. MATERIALS AND METHODS BRAF mutation status was determined in 2001 surgically resected nonsmall-cell lung cancer (NSCLC) cases usi...
متن کاملAn IMRT/VMAT Technique for Nonsmall Cell Lung Cancer
The study is to investigate a Hybrid IMRT/VMAT technique which combines intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for the treatment of nonsmall cell lung cancer (NSCLC). Two partial arcs VMAT, 5-field IMRT, and hybrid plans were created for 15 patients with NSCLC. The hybrid plans were combination of 2 partial arcs VMAT and 5-field IMRT. The dose d...
متن کاملTumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10.
T he origin, progression and dissemination of solid tumours are strongly regulated by stromal, endothelial or defence-related cells [1]. Tumour cells do not merely grow into an inert interstitial tissue, but they actively interact with their microenvironment establishing cell-to-cell contacts, releasing soluble factors and responding to soluble factors released by neighbouring cells. In recent ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomolecules
سال: 2019
ISSN: 2218-273X
DOI: 10.3390/biom9050203